Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Lubricants & Glidants
Empty Capsules
Direct Compression
Coating Systems & Additives
Co-Processed Excipients
Thickeners and Stabilizers
Granulation
Film Formers & Plasticizers
Coloring Agents
Controlled & Modified Release
Taste Masking
Emulsifying Agents
Parenteral
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Bismuth Subcitrate Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bismuth Subcitrate Potassium, including repackagers and relabelers. The FDA regulates Bismuth Subcitrate Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bismuth Subcitrate Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bismuth Subcitrate Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bismuth Subcitrate Potassium supplier is an individual or a company that provides Bismuth Subcitrate Potassium active pharmaceutical ingredient (API) or Bismuth Subcitrate Potassium finished formulations upon request. The Bismuth Subcitrate Potassium suppliers may include Bismuth Subcitrate Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Bismuth Subcitrate Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bismuth Subcitrate Potassium DMF (Drug Master File) is a document detailing the whole manufacturing process of Bismuth Subcitrate Potassium active pharmaceutical ingredient (API) in detail. Different forms of Bismuth Subcitrate Potassium DMFs exist exist since differing nations have different regulations, such as Bismuth Subcitrate Potassium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bismuth Subcitrate Potassium DMF submitted to regulatory agencies in the US is known as a USDMF. Bismuth Subcitrate Potassium USDMF includes data on Bismuth Subcitrate Potassium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bismuth Subcitrate Potassium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bismuth Subcitrate Potassium suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bismuth Subcitrate Potassium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bismuth Subcitrate Potassium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bismuth Subcitrate Potassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bismuth Subcitrate Potassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bismuth Subcitrate Potassium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bismuth Subcitrate Potassium suppliers with NDC on PharmaCompass.
Bismuth Subcitrate Potassium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bismuth Subcitrate Potassium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bismuth Subcitrate Potassium GMP manufacturer or Bismuth Subcitrate Potassium GMP API supplier for your needs.
A Bismuth Subcitrate Potassium CoA (Certificate of Analysis) is a formal document that attests to Bismuth Subcitrate Potassium's compliance with Bismuth Subcitrate Potassium specifications and serves as a tool for batch-level quality control.
Bismuth Subcitrate Potassium CoA mostly includes findings from lab analyses of a specific batch. For each Bismuth Subcitrate Potassium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bismuth Subcitrate Potassium may be tested according to a variety of international standards, such as European Pharmacopoeia (Bismuth Subcitrate Potassium EP), Bismuth Subcitrate Potassium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bismuth Subcitrate Potassium USP).
LOOKING FOR A SUPPLIER?
